Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Becton, Dickinson and Company BDXB NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
64/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Becton, Dickinson and Company (BDXB) — Analyst outlook / Analyst consensus target is. Based on 30 analyst ratings, the consensus is bullish — 16 Buy, 13 Hold, 1 Sell.

BDXB Analyst Ratings

Buy
30
Ratings
16 Buy
13 Hold
1 Sell
Based on 30 analysts giving stock ratings to Becton, Dickinson and Company in the past 3 months
Rating breakdown
Buy
16 53%
Hold
13 43%
Sell
1 3%
53%
Buy
16 analysts
43%
Hold
13 analysts
3%
Sell
1 analysts

People Also View

BSX-PA
BSX-PA
Boston Scientific Corporation
$122.18
+2.37%
 BHFAP
BHFAP
Brighthouse Financial, Inc.
$16.43
+1.23%
 BHFAO
BHFAO
Brighthouse Financial, Inc.
$16.98
+1.49%
 BHFAN
BHFAN
Brighthouse Financial, Inc.
$13.39
+0.45%
 AEPPZ
AEPPZ
American Electric Power Company, Inc.
$47.12
-1.09%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message